Loading...
*  Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery - Full Text View -...
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ...
  https://clinicaltrials.gov/ct2/show/NCT00827931
*  Plus it
Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery. Ann Pharmacother2001;35:1075-84. ... Gill JB, Chin Y, Levin A, Feng D. The use of antifibrinolytic agents in spine surgery. A meta-analysis. J Bone Joint Surg Am ... Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev2008(3):CD006883. ... Gill JB, Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty2006;21:869 ...
  http://www.bmj.com/content/344/bmj.e3054
*  Aminocaproic Acid - Supplements
Aminocaproic acid is an anti-fibrinolytic agent (an agent that prevents the breakdown of fibrin, a protein needed for proper ...
  http://www.lifelearn-cliented.com/iframe.php?action=view&clinic=4305&rid=234&c=&print=1
*  Amicar - Aminocaproic Acid (Intravenous Route) - Drugs & Supplements
Aminocaproic acid injection is an antifibrinolytic agent. It is used to treat serious bleeding conditions, especially when the ... Aminocaproic acid injection is an antifibrinolytic agent. It is used to treat serious bleeding conditions, especially when the ...
  http://pharmacypedia.org/drugs-and-supplements/amicar-aminocaproic-acid-intravenous-route/
*  Each 5 ml ampoule of CYKLOKAPRON solution for injection contains 500 mg tranexamic acid and 5 ml Water for Injections as the...
While an antifibrinolytic effect in the infant is unlikely at therapeutic doses, caution should be exercised when tranexamic ... Anticoagulation dosing at UCDMC (SC=subcutaneously; CI=continuous infusion) Indication Agent Dose Comments Prophylaxis Any or ... The benefit of an antifibrinolytic drug in neonates and infants aged , 2 year old is questionable, as bleeding under CPB in ... In addition, in cases of massive renal haemorrhage of any cause, antifibrinolytic therapy carries the risk of clot retention in ...
  http://docplayer.net/334608-Each-5-ml-ampoule-of-cyklokapron-solution-for-injection-contains-500-mg-tranexamic-acid-and-5-ml-water-for-injections-as-the-inactive-ingredient.html
*  Tranexamic acid - Wikipedia
In melasma - tranexamic acid is sometimes used in skin whitening as a topical agent, injected into a lesion, or taken by mouth ... It serves as an antifibrinolytic by reversibly binding four to five lysine receptor sites on plasminogen or plasmin. This ... Tranexamic acid has roughly eight times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid.[citation ... World Maternal Antifibrinolytic) trial has been in progress worldwide to establish the efficacy of the drug to arrest ...
  https://en.wikipedia.org/wiki/Tranexamic_acid
*  Amicar (Aminocaproic Acid): Side Effects, Interactions, Warning, Dosage & Uses
... vasospasm associated with the use of antifibrinolytic agents in the treatment of subarachnoid hemorrhage (SAH). All of these ...
  https://www.rxlist.com/amicar-drug.htm
*  Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery? - Full Text View -...
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ... Antifibrinolytic medications such as tranexamic acid, aprotinin, and aminocaproic acid have proven to be useful in decreasing ...
  https://clinicaltrials.gov/ct2/show/NCT01714336
*  Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery - Tabular View -...
Tranexamic acid is a safe and effective agent used to achieve hemostasis during operative procedures. The current study is a ... Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D. Anti-fibrinolytic use for ... Background: Tranexamic acid is an antifibrinolytic that prevents the activation of plasminogen to plasmin. Plasmin is ...
  https://clinicaltrials.gov/ct2/show/record/NCT01111669
*  Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI) | BMC Biochemistry | Full Text
The anti fibrinolytic function of bovine TAFIa was tested and compared to that of human TAFIa in a purified system. Clott ... a chelating agent and known carboxypeptidase inhibitor (Fig 4B). This confirms that bovine TAFI has genuine intrinsic activity ... A small anti fibrinolytic effect was observed upon addition of 1 μg of bovine TAFI (open circles) and human TAFI (open squares ... Sakharov DV, Plow EF, Rijken DC: On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem. ...
  https://bmcbiochem.biomedcentral.com/articles/10.1186/1471-2091-10-13
*  Tranexamic Acid Injection - Zuche Pharmaceuticals
Tranexamic acid belongs to the class of medications called antifibrinolytic agents. Tranexamic acid (TXA) is a medication used ...
  http://zuchepharma.com/pharmaceuticals/tranexamic-acid-injection/
*  Pediatric Angioedema Medication: Androgens, Antifibrinolytic Agents, Blood Products, Sympathomimetic Agents, Kallikrein...
Antifibrinolytic Agents. Class Summary. These agents have been successfully used as preventive therapy. The effect may depend ... Sympathomimetic Agents. Class Summary. These agents directly or indirectly stimulate adrenergic receptors. They are used as ... Aminocaproic acid is an antifibrinolytic agent used for immediate short-term treatment of angioedema. It inhibits fibrinolysis ... This agent increases levels of C4 component of complement and reduces attacks associated with angioedema. In HAE, danazol ...
  https://emedicine.medscape.com/article/885100-medication
*  Tioconazolum [INN-Latin] - Antifibrinolytic Agents, ATC:B02AA02
Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is ...
  http://pharmacycode.com/Tioconazolum_%5BINN-Latin%5D.html
*  Mephyton (TN) - Antifibrinolytic Agents, Vitamins (Vitamin K)
Phytonadione is a vitamin, indicated in the treatment of coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. Phytonadione aqueous colloidal solution of vitamin K1 for parenteral injection, possesses the same type and degree of activity as does naturally-occurring vitamin K, which is necessary for the production via the liver of active prothrombin (factor II), proconvertin (factor VII), plasma thromboplastin component (factor IX), and Stuart factor (factor X ...
  http://pharmacycode.com/Mephyton_%28TN%29.html
*  Apitherapy News: Bee Venom Peptide is Anti-Fibrinolytic, Anti-Microbial Agent
Bee Venom Peptide is Anti-Fibrinolytic, Anti-Microbial Agent Secapin, a bee venom peptide, exhibits anti-fibrinolytic, anti- ... venom peptide secapin has multifunctional roles as an anti-fibrinolytic agent during fibrinolysis and an anti-microbial agent ... thus indicating the role of AcSecapin-1 as an anti-fibrinolytic agent. AcSecapin-1 also inhibited both human neutrophil and ... Here, we provide the evidence that Asiatic honeybee (Apis cerana) secapin (AcSecapin-1) exhibits anti-fibrinolytic, anti- ...
  http://apitherapy.blogspot.com/2016/05/bee-venom-peptide-is-anti-fibrinolytic.html
*  Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage - Full Text View - ClinicalTrials.gov
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ... Coats T, Hunt B, Roberts I, Shakur H. Antifibrinolytic agents in traumatic haemorrhage. PLoS Med. 2005 Mar;2(3):e64. Epub 2005 ... as to whether or not to use an antifibrinolytic agent in a particular adult with traumatic haemorrhage. Patients for whom the ... eligible if the responsible doctor is for any reason substantially uncertain whether or not to use an antifibrinolytic agent. ...
  https://clinicaltrials.gov/show/NCT00375258
*  An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra)...
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ... Reversal of VKA therapy alone may not resolve the coagulopathy (eg, receiving a potent anti-platelet agent, i.e., clopidogrel ...
  https://clinicaltrials.gov/ct2/show/NCT00803101?term=Blood+Coagulation+Disorders%3A+Clinical+Trials&rank=11
*  Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease - Full Text View - ClinicalTrials.gov
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ... Willingness to avoid aspirin (ASA) and nonsteroidal anti-inflammatory agents (NSAIDS) during the study. ... and any drugs or hemostatic agents taken. ...
  https://www.clinicaltrials.gov/ct2/show/NCT02606045?term=Inherited+Bleeding+Disorder&
*  Hemostatic and Anti-Inflammatory Effects of Ulinastatin and Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery - Full...
Anti-Inflammatory Agents. Urinastatin. Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of ... The extensively studied antifibrinolytic drug aprotinin is efficacious but expensive, and has been proved to link to higher ... An effective and secure hemostatic agent is badly needed. Ulinastatin, urinary trypsin inhibitor(UTI), is a secreted Kunitz- ... Limited studies offered clues to its antifibrinolytic effect. Tranexamic acid has been applied for years with convinced ...
  https://clinicaltrials.gov/ct2/show/NCT01060189
*  Tinzaparin in the Treatment of the Acute Pulmonary Embolism - Full Text View - ClinicalTrials.gov
Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. Hemostatics. Coagulants. ...
  https://clinicaltrials.gov/ct2/show/NCT00711308